Genflow Biosciences plcHere is the public summary page for Genflow Biosciences plc. Please login to see the complete information for Genflow Biosciences plc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Genflow Biosciences plc stacks up relative to its peers. |
| Darwin Score | -27 |
| Ticker | GENF |
| Latest Price | 0.01 GBP as of close on 15-Aug-2025 |
| 3 Month price range | 0.01 to 0.01 GBP |
| Market Capitalisation | 3.01Mn GBP |
| Country | UK |
| Region | Europe |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducing the incidence of age-related diseases. Its lead drug candidate is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-1003, a topical delivery of SIRT6 to the fibroblasts in the skin; GF-1004, a non-human pipeline anti-aging for veterinary use; GF-1005, which addresses mitochondrial dysfunction observed in sarcopenia for muscle health and combat sarcopenia; and GF-1006, an ophthalmology mRNA cent SIRT6 for the treatment of cornea pathologies and glaucoma. The company has collaborative research agreements with Revatis SA and EXO Biologics for therapy medicinal products. Genflow Biosciences plc was founded in 2020 and is headquartered in London, the United Kingdom. See More ... |
| Company URL | https://genflowbio.com |
| See Darwins Full Analysis for Genflow Biosciences plc |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Genflow Biosciences plc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -14 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -4 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -9 |
Alerts
There are 8 live alerts for Genflow Biosciences plc.
- Oversold - The 5 month RSI is +5.6. (Positive)
- Oversold - The 15 month RSI is +25.9. (Positive)
- Oversold - The 30 month RSI is +25.5. (Positive)
- New Low (1m). (Negative)
- New Low (6m). (Negative)
- 5d RSI Oversold. (Negative)
- New Low (12m). (Negative)
- New Low (3m). (Negative)
Peer Comparison
There are 29 peers of Genflow Biosciences plc.
Share 
